Mass Tort brief
Mass Tort: Bellwethers, Preemption Battles, and Screening Impasses
Federal dockets test product design theories in Roundup, break infant formula momentum, and press Camp Lejeune toward global matrix deadlines.
Mass Tort
Mead Johnson secured a complete federal defense verdict — ending plaintiff momentum in federal court and raising the bar for baby formula claims.
BackgroundParents of premature infants filed thousands of lawsuits alleging that cow's-milk-based formula products substantially increase the risk of necrotizing enterocolitis. State court trials in Illinois and Missouri had previously hit manufacturers with massive compensatory and punitive verdicts.
- The federal jury in Chicago determined Mead Johnson provided adequate clinical warnings to neonatal intensive care physicians regarding NEC risks.
- The defense verdict contrasts with Abbott's previous state trial losses, including a $495 million verdict later settled within a broader $670 million agreement.
- Approximately 844 actions remain pending in federal MDL 3026, where the defense verdict provides formula manufacturers substantial leverage in upcoming trials.
Mass Tort
Roundup plaintiffs shifted to defective design claims in St. Louis — testing whether negligence claims can survive the Supreme Court's preemption ruling.
BackgroundBayer has faced tens of thousands of product liability lawsuits alleging that glyphosate-based herbicide Roundup causes non-Hodgkin lymphoma. The Supreme Court curbed state failure-to-warn claims by establishing that EPA-approved pesticide labels preempt state warning mandates.
- The Supreme Court vacated a $28 million California appellate verdict in Dennis v. Monsanto, ordering state courts to reconsider awards under federal preemption rules.
- Plaintiffs' trial counsel pivoted to claims that Monsanto negligently formulated and tested the herbicide rather than relying on warning omissions.
- More than 61,000 claims remain pending nationwide while a Missouri state judge reviews Bayer's proposed $7.25 billion 21-year settlement framework.
Mass Tort
Camp Lejeune negotiations stalled over medical screening demands — forcing plaintiffs and federal lawyers to narrow hundreds of conditions into a workable matrix.
BackgroundThe Camp Lejeune Justice Act allows military veterans and their families to seek federal compensation for illnesses linked to contaminated base water supplies. Over 408,000 administrative filings and 3,700 federal lawsuits have overwhelmed the Eastern District of North Carolina with extensive discovery burdens.
- Plaintiffs' leadership requested a formal census covering 25 specific disease categories to create a functional global matrix, abandoning unprovable peripheral conditions.
- The Justice Department countered with a Lone Pine motion demanding plaintiffs submit expert causation reports and verified medical records for all non-core illnesses.
- Federal judges established an October 30 deadline to agree on settlement parameters, as administrative payouts across early cases reached $879 million.
Mass Tort
Federal judges locked in five bellwether trials for chemical hair relaxers — putting 12,381 cancer claims on a direct path toward trial.
BackgroundEpidemiological studies published in recent years linked frequent use of chemical hair straightening products to significantly higher risks of uterine neoplasms. Thousands of women filed personal injury lawsuits against cosmetics corporations, prompting federal judicial consolidation in Chicago.
- Summary judgment motions and Daubert expert challenges on general causation are scheduled for formal briefing through January 2027.
- Judge Rowland lifted stays protecting secondary manufacturers, expanding depositions across companies including Wella, Bronner Bros, and Murray's.
- Lead defendant L'Oréal continues evaluating liability management structures as active case counts in MDL 3060 rose past 12,300 filings.
Mass Tort
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.
